Pfizer, Moderna Vaccines Highly Effective Even After 1st Jab, Says US Study
New York: COVID-19 vaccines developed by BioNTech SE and Moderna lowered the infection risk by 80 per cent two weeks or more after the first jab, revealed the data from a real-world study of…